Cevimeline Hydrochloride (Apotex Corp.)


Welcome to the PulseAid listing for the Cevimeline Hydrochloride drug offered from Apotex Corp.. This Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Apotex Corp.
NON-PROPRIETARY NAME: cevimeline hydrochloride
SUBSTANCE NAME: CEVIMELINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-10-08
END MARKETING DATE: 0000-00-00


Cevimeline Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCevimeline Hydrochloride from Apotex Corp.
LABELER NAME: Apotex Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 30(mg/1)
START MARKETING DATE: 2012-10-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 60505-3145_1d0c0c59-07c0-bc3d-726d-d1513c6a3391
PRODUCT NDC: 60505-3145
APPLICATION NUMBER: ANDA091260

Other CEVIMELINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Health PackagingCevimeline Hydrochloride
Apotex Corp.Cevimeline Hydrochloride
Avera McKennan HospitalCevimeline Hydrochloride
Daiichi Sankyo Pharma DevelopmentEvoxac
Ingenus Pharmaceuticals NJ, LLCCEVIMELINE HYDROCHLORIDE
Ranbaxy Pharmaceuticals Inc.Cevimeline
Rising Pharmaceuticals, Inc.Cevimeline Hydrochloride
STAT RX USA LLCEVOXAC
West-Ward Pharmaceuticals Corp.Cevimeline Hydrochloride